Tenaya Therapeutics, Inc. (TNYA): Total Assets
$146.92M
As of 2025-12-31
$93.54M
As of 2026-06-30
-19.2%
3-year compound annual growth
-0.2%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $146.92M | +22.5% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $119.94M | -29.7% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $170.51M | -38.9% | 2025-03-10, Balance as of period end |
| 2022-12-31 | $278.94M | -11.2% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $314.19M | +112.1% | 2023-03-08, Balance as of period end |
| 2020-12-31 | $148.16M | n/a | 2022-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | 2025-12-31 | $146.92M | +22.5% |
| Inhibrx Biosciences, Inc. (INBX) | 2025-12-31 | $146.48M | -19.0% |
| Black Diamond Therapeutics, Inc. (BDTX) | 2025-12-31 | $143.01M | +16.6% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $152.98M | +860.8% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $154.42M | +13.2% |
| Compugen Ltd (CGEN) | 2025-12-31 | $156.57M | +36.2% |
| Palisade Bio, Inc. (PALI) | 2025-12-31 | $134.34M | n/m |
| Artiva Biotherapeutics, Inc. (ARTV) | 2025-12-31 | $130.94M | -37.5% |
| Cabaletta Bio, Inc. (CABA) | 2025-12-31 | $165.08M | -10.8% |
Compare TNYA, INBX, BDTX, IMA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗